SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-031528
Filing Date
2019-08-12
Accepted
2019-08-12 17:05:26
Documents
66
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q trvi-10q_20190630.htm 10-Q 2842747
2 EX-31.1 trvi-ex311_92.htm EX-31.1 14075
3 EX-31.2 trvi-ex312_91.htm EX-31.2 13926
4 EX-32.1 trvi-ex321_89.htm EX-32.1 9527
5 EX-32.2 trvi-ex322_90.htm EX-32.2 9649
  Complete submission text file 0001564590-19-031528.txt   8018411

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT trvi-20190630.xml EX-101.INS 1454451
7 XBRL TAXONOMY EXTENSION SCHEMA trvi-20190630.xsd EX-101.SCH 61212
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE trvi-20190630_cal.xml EX-101.CAL 43917
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE trvi-20190630_def.xml EX-101.DEF 193114
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE trvi-20190630_lab.xml EX-101.LAB 425674
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE trvi-20190630_pre.xml EX-101.PRE 331277
Mailing Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510
Business Address 195 CHURCH STREET 14TH FLOOR NEW HAVEN CT 06510 203-304-2499
Trevi Therapeutics, Inc. (Filer) CIK: 0001563880 (see all company filings)

IRS No.: 450834299 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38886 | Film No.: 191017338
SIC: 2834 Pharmaceutical Preparations